Dc Global VenturesFirm match from fund name (lower confidence)
Decheng Capital Global Life Sciences Fund V, L.P.
Open: first sale Jun 2024, per Form D (fund age approximates vintage)
- Vintage
- 2024
- Fund size
- $452M to $700M (Form D)
- Stages
- Seed, Series A, Growth
- Sectors
- Biotech, Medical devices, Healthtech, Life sciences and research tools
- Regions
- Global
01 · Thesis
Provides capital and strategic support to early-stage life science companies with revolutionary technologies and growth-stage healthcare companies with strong market presence.Inferred from the firm's website
02 · Initial check
$4.52M to $11.67M (estimated from fund size)
Estimated from Form D: $452M sold of a $700M target
03 · Who to approach
Named on this fund's Form D
- Xiangmin Cui, Manager of the General Partner of the Issuers
- Yuheng Qiu, Manager of the General Partner of the Issuers
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideDecheng Capital is an investment firm that provides capital and strategic support to early-stage life science companies with revolutionary technologies and growth stage healthcare companies with strong market presence.
Decheng Capital is an investment firm that provides capital and strategic support to early-stage life science companies with revolutionary technologies and growth stage healthcare companies with strong market presence.
http://www.decheng.com/
06 · Sources
Last verified: Oct 28, 2026